Jane Street Group, LLC Galapagos Nv Put Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	BUY	$51.32 - $68.5 $1.24 Million - $1.65 Million	24,100 Added 602.5%	28,100 $1.74 Million
Q3 2021 Nov 16, 2021	SELL	$52.17 - $70.2 $88,689 - $119,340	-1,700 Reduced 29.82%	4,000 $210,000
Q2 2021 Aug 16, 2021	SELL	$68.86 - $83.34 $1.58 Million - $1.92 Million	-23,000 Reduced 80.14%	5,700 $393,000
Q1 2021 May 18, 2021	SELL	$76.15 - $111.94 $2.23 Million - $3.28 Million	-29,300 Reduced 50.52%	28,700 $2.21 Million
Q4 2020 Feb 17, 2021	SELL	$96.85 - $148.25 $145,275 - $222,375	-1,500 Reduced 2.52%	58,000 $5.74 Million
Q3 2020 Nov 17, 2020	BUY	$122.47 - $213.56 $7.29 Million - $12.7 Million	59,500 New	59,500 $8.44 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.